Claritev Shares Slip on Secondary Offering

Dow Jones

2025/11/13

By Connor Hart

Shares of Claritev fell after the healthcare technology company said certain affiliates of Hellman & Friedman will sell 1.5 million shares of its common stock to the public at $51.50 apiece.

The stock slid 9.6% to $53.43 in premarket trading Thursday. Through Wednesday's close, shares had nearly quadrupled so far this year.

The McLean, Va.-based company said late Wednesday that the selling shareholders will also grant underwriters a 30-day option to purchase up to an additional 225,000 shares.

Claritev won't sell any shares in the offering or receive any proceeds. The offering is expected to close by Friday.

Barclays, Guggenheim Securities and Wells Fargo Securities are acting as joint lead bookrunners for the deal, with Citigroup and Piper Sandler serving as additional bookrunners.

Write to Connor Hart at connor.hart@wsj.com

(END) Dow Jones Newswires

November 13, 2025 08:36 ET (13:36 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2583593606"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2583593606\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2583593606?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-13 21:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583593606","market":"hk","top_or_hot":-1,"title":"Claritev Shares Slip on Secondary Offering","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Connor Hart \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Claritev fell after the healthcare technology company said certain affiliates of Hellman &amp; Friedman will sell 1.5 million shares of its common stock to the public at $51.50 apiece. \n</p>\n<p>\n  The stock slid 9.6% to $53.43 in premarket trading Thursday. Through Wednesday's close, shares had nearly quadrupled so far this year. \n</p>\n<p>\n  The McLean, Va.-based company said late Wednesday that the selling shareholders will also grant underwriters a 30-day option to purchase up to an additional 225,000 shares. \n</p>\n<p>\n  Claritev won't sell any shares in the offering or receive any proceeds. The offering is expected to close by Friday. \n</p>\n<p>\n  Barclays, Guggenheim Securities and <a href=\"https://laohu8.com/S/EOD\">Wells Fargo</a> Securities are acting as joint lead bookrunners for the deal, with Citigroup and Piper Sandler serving as additional bookrunners. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 13, 2025 08:36 ET (13:36 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Claritev Shares Slip on Secondary Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClaritev Shares Slip on Secondary Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-11-13 21:36</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Connor Hart \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Claritev fell after the healthcare technology company said certain affiliates of Hellman &amp; Friedman will sell 1.5 million shares of its common stock to the public at $51.50 apiece. \n</p>\n<p>\n  The stock slid 9.6% to $53.43 in premarket trading Thursday. Through Wednesday's close, shares had nearly quadrupled so far this year. \n</p>\n<p>\n  The McLean, Va.-based company said late Wednesday that the selling shareholders will also grant underwriters a 30-day option to purchase up to an additional 225,000 shares. \n</p>\n<p>\n  Claritev won't sell any shares in the offering or receive any proceeds. The offering is expected to close by Friday. \n</p>\n<p>\n  Barclays, Guggenheim Securities and <a href=\"https://laohu8.com/S/EOD\">Wells Fargo</a> Securities are acting as joint lead bookrunners for the deal, with Citigroup and Piper Sandler serving as additional bookrunners. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 13, 2025 08:36 ET (13:36 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CTEV","symbol_name":"Claritev Corporation","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2583593606","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2583593606","pubTimestamp":1763040960,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Claritev fell after the healthcare technology company said certain affiliates of Hellman & Friedman will sell 1.5 million shares of its common stock to the public at $51.50 apiece.The stock slid 9.6% to $53.43 in premarket trading Thursday. Through Wednesday's close, shares had nearly quadrupled so far this year.The McLean, Va.-based company said late Wednesday that the selling shareholders will also grant underwriters a 30-day option to purchase up to an additional 225,000 shares.Claritev won't sell any shares in the offering or receive any proceeds. The offering is expected to close by Friday.Barclays, Guggenheim Securities and Wells Fargo Securities are acting as joint lead bookrunners for the deal, with Citigroup and Piper Sandler serving as additional bookrunners.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CTEV":"Claritev Corporation","BK4167":"医疗保健技术"},"translate_title":"Claritev股价因二次发行而下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CTEV":0.9},"content_text":"By Connor Hart \n\n\n \n\n\n  Shares of Claritev fell after the healthcare technology company said certain affiliates of Hellman & Friedman will sell 1.5 million shares of its common stock to the public at $51.50 apiece. \n\n\n  The stock slid 9.6% to $53.43 in premarket trading Thursday. Through Wednesday's close, shares had nearly quadrupled so far this year. \n\n\n  The McLean, Va.-based company said late Wednesday that the selling shareholders will also grant underwriters a 30-day option to purchase up to an additional 225,000 shares. \n\n\n  Claritev won't sell any shares in the offering or receive any proceeds. The offering is expected to close by Friday. \n\n\n  Barclays, Guggenheim Securities and Wells Fargo Securities are acting as joint lead bookrunners for the deal, with Citigroup and Piper Sandler serving as additional bookrunners. \n\n\n \n\n\n  Write to Connor Hart at connor.hart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 13, 2025 08:36 ET (13:36 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}